4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-046108
CEO disposed of 10,243 shares (other)
- CEO acquired 17,762 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gline Matthew · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-27 | Exercise or conversion : show line 1 in the form | +17,762 | 1,051,483 | D | ||
| 2023-09-28 | Other disposition : show line 2 in the form | −10,243 | $12.67 | $129,779 | 1,041,240 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-27 | Exercise or conversion : show line 3 in the form Capped Value Appreciation Rights | −28,411 | $6.40 | $181,830 | 1,164,836 | D |
| 2023-09-27 | Exercise or conversion : show line 4 in the form Capped Value Appreciation Rights | −47,351 | $11.50 | $544,537 | 2,225,501 | D |
Loading xslF345X05/form4.xml…